Buse Rahime HASIRCI BAYIR, Gülbün Asuman YÜKSEL, Ceyhun SAYMAN, Gizem GÜRSOY, Yılmaz ÇETINKAYA

Primer baş ağrılarında büyük oksipital sinir blokajı etkin bir tedavi yöntemi mi?

Amaç: Baş ağrısı en yaygın görülen sağlık sorunlarından biri olup, yaşam kalitesini ciddi şekilde bozmaktadır. Bu çalışmada primer baş ağrısı tanısıyla takip edilen hastalarda büyük oksipital sinir blokajı etkinliği değerlendirilmiştir. Gereç ve Yöntem: Mart 2017-Haziran 2018 tarihleri arasında baş ağrısı polikliniğinde takip edilen 53 hasta baş ağrısı tipi, atak süresi, atak sıklığı, ağrı şiddeti ve ilaç kullanımı açısından değerlendirilmiş ve başlangıç değerleri ile 1. ay, 3. ay, 6. ay takip değerleri kıyaslanmıştır. Bulgular: Çalışmaya 36 epizodik migren, 12 gerilim tipi baş ağrısı, 4 kronik migren ve 1 küme tipi baş ağrısı dahil edilmiştir. Migren ve gerilim tipi baş ağrısı grubunda VAS değeri, atak süresi, aylık atak ve ilaç sayısı ortalaması, 3 aylık takip süresi boyunca başlangıç değerlerine kıyasla istatistiksel olarak anlamlı ölçüde azalmıştır. Sonuç: Tekrarlanan büyük oksipital sinir blokajı migren ve gerilim tipi baş ağrısında etkili bulunmuştur.

Greater occipital nerve block is an effective treatment method for primary headaches?

Objectives: Headache is one of the most common health problems, and it severely reduces the quality of life. The present study examines the efficacy of greater occipital nerve (GON) block in patients monitored for primary headaches. Methods: The present study includes 53 patients monitored by the headache outpatient clinic from March 2017 to June 2018, evaluates them for headache type, attack duration, attack frequency, severity of pain, and analgesic intake and compares the initial values with the follow-up values at months 1, 3, and 6. Results: The study group comprises 36 episodic migraine cases, 12 tension-type headache (TTH) cases, 4 chronic migraine cases, and 1 cluster headache case. In migraine group, VAS scores, attack durations, and the mean value of monthly number of attacks and analgesics taken significantly decrease compared to initial values at the end of the 6-month follow-up period. In TTH group, VAS scores, attack durations, and the mean value of monthly number of attacks and analgesics taken significantly decrease compared to initial values at the end of the 3-month follow-up period. Since only 2 of 12 patients completed the 6-month follow-up, although there was a decrease in the 6-month data, it was found to be statistically insignificant. Conclusion: Repetitive GON block is an effective treatment method for migraine and TTH.

PDF

___

1. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990- 2013: a systematic analysis for the global burden of disease study 2013. Lancet 2015;386(9995):743–800.
2. Saip S. Başağrısı bozukluklarinin siniflanmasi. In: İnan LE, editor. Nörolojide Yeni Ufuklar: Başağrıları. Turkey: Güneş Tıp Kitabevi; 2011. p. 15–32. (Turkish)
3. Arnold M. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia 2018;38(1):1–211.
4. Levin M. Nerve blocks in the treatment of headache. Neurotherapeutics 2010;7(2):197–203.
5. İnan N. Nerve blocks in headache treatment. Turkiye Klinikleri J Neurol-Special Topics 2018;11(1):120–4. (Turkish)
6. Reed K, Black S, Banta C, Will K. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: Initial experience. Cephalalgia 2010;30(3):260–71.
7. Piovesan E, Kowacs P, Tatsui C, Lange M, Ribas L, Werneck L. Referred pain after painful stimulation of the greater occipital nerve in humans: Evidence of convergence of cervical afferences on trigeminal nuclei. Cephalalgia 2001;21(2):107–9.
8. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 2010;9(3):285–98.
9. Silberstein S, Holland S, Freitag F, Dodick DW, Argoff, C, Ashman E. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American academy of neurology and the american headache society. Neurology 2012;78(17):1337–45.
10. Hadden S. Neuralgic headache and facial pain. Arch Neurol 1940;43:405–8.
11. Ashkenazi A, Blumenfeld A, Napchan U, Narouze S, Grosberg B, Nett R, et al. Peripheral nerve blocks and trigger point injections in headache management-a systematic review and suggestions for future research. Headache 2010;50(6):943–52.
12. Allen SM, Mookadam F, Cha SS, Freeman JA, Starling AJ, Mookadam M. Greater occipital nerve block for acute treatment of migraine headache: a large retrospective cohort study. J Am Board Fam Med 2018;31(2):211–8.
13. Wu S, Yang X, Lin Y, Chen L, Ye H. The efficacy of greater occipital nerve block for the treatment of migraine: a systematic review and meta-analysis. Clin Neurol Neurosurg 2018;165:129–33.
14. Terzi T, Karakurum B, Üçler S, İnan LE, Tulunay C. Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache. J Headache Pain 2002;3(3):137–41.
15. Karadaş Ö, Öztürk B, İnan L, İnan N. Comparison of single and repeated blockade of the greater occipital nerve in migraine treatment. J Neurol Sci 2018;35(2):97–101.
16. Çatav S, Solmaz FA, Kırdemir P. The results of greater occipital nerve block applied for migraine headache. Agri 2017;29(1):33–7. (Turkish)
17. Fernandes L, Khan N, Dobson J, Randall M, Idrovo L. Multiple cranial nerve blocks as an alternative preventative therapy for chronic migraine. Headache 2020;60(5):981–7.
18. Shawagfeh M, Melhem GB, Khsawneh J, Awida M, Alamaerah T, Al-Soud N. The effect of bilateral block of greater occipital nerve on chronic migraine. JRMS 2017;24(3):57–61.
19. Leinisch-Dahlke E, Jürgens T, Bogdahn U, Jakob W, May A. Greater occipital nerve block is ineffective in chronic tension type headache. Cephalalgia 2005;25(9):704–8.
20. Peres M, Stiles M, Siow H, Rozen T, Young W, Silberstein SD. Greater occipital nerve blockade for cluster headache. Cephalalgia 2002;22(7):520–2.
21. Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, et al. Suboccipital injection with a mixture of rapid-and long-acting steroids in cluster headache: A double-blind placebo-controlled study. Pain 2005;118(1–2):92–6.
22. Hoydonckx Y, Peng P. Greater and lesser occipital nerve. In: Peng P, Finlayson R, Lee SH, Bhatia A, editors. Ultrasound for interventional pain management. 1st ed. Berlin, Germany: Springer; 2020. p. 33–42.
23. Shields K, Levy M, Goadsby P. Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid. Neurology 2004;63(11):2193–4.